Antitumor effects of MutT homolog 1 inhibitors in human bladder cancer cells

Bioscience, Biotechnology, and Biochemistry
Jeong Woo LeeEunsik Lee

Abstract

As standard second-line regimen has not been established for patients who are refractory to or relapse with cisplatin-based chemotherapy, an effective class of novel chemotherapeutic agents is needed for cisplatin-resistant bladder cancer. Recent publications reported that MutT homolog 1 (MTH1) inhibitors suppress tumor growth and induce impressive therapeutic responses in a variety of human cancer cells. Few studies investigated the cytotoxic effects of MTH1 inhibitors in human bladder cancer. Accordingly, we investigated the antitumor effects and the possible molecular mechanisms of MTH1 inhibitors in cisplatin-sensitive (T24) and - resistant (T24R2) human bladder cancer cell lines. These results suggest that TH588 or TH287 may induce cancer cell suppression by off-target effects such as alterations in the expression of apoptosis- and cell cycle-related proteins rather than MTH1 inhibition in cisplatin-sensitive and - resistant bladder cancer cells.Abbreviations: MTH: MutT homolog; ROS: reactive oxygen species; CCK-8: cell counting kit-8; DCFH-DA: dichlorofluorescein diacetate; PARP: poly (ADP-ribose) polymerase.

References

May 2, 1990·Journal of the National Cancer Institute·C M SorensonA Eastman
Jun 22, 2006·Medicinal Chemistry·Morgane Le BrasCatherine Brenner
Aug 17, 2006·Antioxidants & Redox Signaling·David Gius, Douglas R Spitz
Jun 11, 2009·Acta Oncologica·Claudia BurzAlexandru Irimie
Sep 22, 2009·Antioxidants & Redox Signaling·Meihua LuoMillie M Georgiadis
Jul 22, 2010·Biochimica Et Biophysica Acta·Beate KöberleBernd Kaina
Apr 5, 2011·Antioxidants & Redox Signaling·Yuxing ZhangJi Zhang
Apr 4, 2014·Nature·Kilian V M HuberGiulio Superti-Furga
Jul 25, 2014·European Journal of Pharmacology·Shaloam Dasari, Paul Bernard Tchounwou
Feb 18, 2016·Journal of Medicinal Chemistry·Jason G KettleMarta Wylot
Feb 24, 2016·Bioorganic & Medicinal Chemistry Letters·Alessia PetrocchiRichard T Lewis

❮ Previous
Next ❯

Citations

Feb 23, 2020·Cancer Biotherapy & Radiopharmaceuticals·Dankai ZhanJianguang Jia

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft
flow cytometry

Software Mentioned

SPSS

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis